Roy MD

Dr. Fleischmann is a Clinical Professor in the Department of Internal Medicine at the University of Texas Southwestern Medical Center and in private practice at Rheumatology Associates, Dallas, Texas. He has served as Chief of the Division of Rheumatology at UTSMC-University Hospitals-St. Paul, Dallas, Texas since 1978. Dr. Fleishmann is Co-Medical Director of Metroplex Clinical Research Center.

He received his Doctor of Medicine (M.D.) from the State University of New York, Downstate Medical Center in 1969, before completing his residency in Internal Medicine at the Mt Sinai Hospital, New York City, New York, and his Fellowship in Rheumatology at the College of Physicians and Surgeons, Columbia University, New York City, New York.

He is a Diplomat of the American Board of Internal Medicine and is a Fellow of the American College of Rheumatology. He has served on the Finance Committee of the American College of Rheumatology and the Fund Raising Committee of the Research and Education Foundation (REF) of the American College of Rheumatology. He has previously served on the Board of Directors and the Executive Committee of the North Texas Chapter of the Arthritis Foundation. He has been President of the Texas Rheumatism Society and has sat on the Governing Board of the Texas Rheumatism Association. Dr. Fleischmann is an internationally recognized thought leader in the areas of education of other rheumatologists and the development of new medications for the treatment of various forms of arthritis. He has been a consultant to many pharmacological companies in the area of trial design, protocol development and CME development. He is a member of the Inflammation Research Association, the Associates of Clinical Pharmacology, and the Drug Information Association. He has been involved in many clinical trials on treatments for osteoarthritis and rheumatoid arthritis, and has published over 60 peer-reviewed articles in these areas. Dr. Fleischmann has been voted one of the "Best Doctors in Dallas" as well as "Texas Super Doctors".